STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $4,680,000 | +40.5% | 300,000 | 0.0% | 0.55% | +15.6% |
Q3 2017 | $3,330,000 | +20.7% | 300,000 | 0.0% | 0.48% | +1.3% |
Q2 2017 | $2,760,000 | +7.6% | 300,000 | 0.0% | 0.47% | -6.4% |
Q1 2017 | $2,565,000 | +119.0% | 300,000 | +270.6% | 0.50% | +310.7% |
Q1 2015 | $1,171,000 | – | 80,957 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |